Re-analysis of the PolyHeme Phase III trial dataset: Lessons for future haemoglobin-based oxygen carrier trauma trials
•New analyses of the PolyHeme Phase III clinical trial database examined adverse early outcomes versus original 30-day mortality; amongst 714 trauma patients, adverse event reporting showed coagulopathy was significantly more frequent after PolyHeme administration than blood in the first 12 h; 10 mo...
Gespeichert in:
Veröffentlicht in: | Injury 2023-09, Vol.54 (9), p.110712-110712, Article 110712 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!